Adverse COVID-19 vaccination effects in Finnish patients with Meniere's disease : a cross-sectional study

Loading...
Thumbnail Image

Authors

Beukes, Eldre W.
Manchaiah, Vinaya
Pyykko, Nora
Pyykko, Ilmari

Journal Title

Journal ISSN

Volume Title

Publisher

F1000 Research Ltd

Abstract

BACKGROUND : The association between reporting adverse coronavirus disease 2019 (COVID-19) vaccination effects and those with a history of audiovestibular difficulties is unknown. The aim of this research is therefore to investigate adverse vaccination effects in adults with a history of Ménière’s disease. Specifically, the incidence of adverse effects, the factors associated with those reporting adverse effects and the relationship between the reporting of audiovestibular and other adverse effects. METHODS : A mixed-methods exploratory cross-sectional survey study design was used. Data were collected from 333 members of the Finnish Ménière Association. The survey was designed to obtain demographic information that may be associated with having adverse effects or not, vaccination-specific information and adverse vaccination effects. Both health and audiovestibular adverse events were identified. Data analysis included comparing those reporting and not reporting adverse vaccination effects. RESULTS : The mean age was 63 years with 81% being female. Of the 327 respondents who had one of the COVID-19 vaccinations (Comirnatry/ Pfizer, Astra Zeneca, or Moderna), 203 (62%) reported no adverse effects. The type of or number of vaccinations were not related to the reporting of adverse effects. The most frequently reported adverse effects were injection site tenderness (38%), arm pain (21%), fever (15%) and headaches (15%). Post-vaccination tinnitus and vertigo (both 7%) were the most frequently reported audiovestibular-related symptoms, followed by aural fullness (6%) and hearing loss (4%). Those reporting previous pre-vaccination vertigo were more likely to have post-vaccination vertigo. The presence of post-vaccination tinnitus, hearing loss, and aural fullness, predicted the presence of post-vaccination vertigo. CONCLUSIONS : A small proportion of patients with a history of Ménière’s disease may experience adverse post-vaccination effects. Further research is required to explore whether adverse postvaccination audiovestibular effects are more prevalent in those with a history of otological disorders compared with the general population.

Description

DATA AVAILABILITY : UNDERLYING DATA : Figshare: COVID 19 vaccine in Ménière’s disease, https://doi.org/10.6084/m9.figshare.19519801. This project contains the following underlying data: - COVID vaccine in MD for repository.xslx (raw data). EXTENDED DATA : Figshare: COVID 19 vaccine in Ménière’s disease, https://doi.org/10.6084/m9.figshare.19519801. This project contains the following extended data: - Finnish_MD COVID Vaccination Questionnaire - English_MD COVID Vaccination Questionnaire - S 1S1 The STROBE Checklist. Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).

Keywords

Meniere’s disease, Audiovestibular, Vertigo, Hearing loss, Tinnitus, COVID-19 pandemic, Coronavirus disease 2019 (COVID-19), Vaccination, SDG-03: Good health and well-being

Sustainable Development Goals

Citation

Beukes, E., Manchaiah. V., Pyykkö, N. and Pyykkö, I. Adverse COVID-19 vaccination effects in Finnish patients with Ménière’s disease: a cross-sectional study. F1000Research 2022, 11:893 https://DOI.org/10.12688/f1000research.113143.1.